Recombinant KLKB1 (Lanadelumab Biosimilar) antibody

Catalog No. ABIN7795153

The Human Monoclonal anti-KLKB1 (Lanadelumab Biosimilar) antibody (ABIN7795153) specifically detects KLKB1 (Lanadelumab Biosimilar) in FACS and in vivo. The antibody is reactive with Human samples.

Quick Overview for Recombinant KLKB1 (Lanadelumab Biosimilar) antibody (ABIN7795153)

Target: KLKB1 (Lanadelumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This KLKB1 (Lanadelumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-KLKB1 (Lanadelumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Lanadelumab Biosimilar, Human KLKB1 Monoclonal Antibody

Characteristics: The anti-human KLKB1 monoclonal antibody lanadelumab biosimilar was produced in mammalian cells.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG1, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for KLKB1 (Lanadelumab Biosimilar)

Target: KLKB1 (Lanadelumab Biosimilar)

Alternative Name: Lanadelumab Biosimilar

Target Type: Biosimilar